Sandu Pharmaceuticals Ltd (SANDUPHQ) share fundamentals
Sandu Pharmaceuticals Ltd is a micro-cap company in Consumer Staples (FMCG - Personal Products) with a market capitalisation of ₹34 crore. Here is where it stands on valuation, profitability, debt and growth as of 5 November 2026, and how it compares with the median Consumer Staples company.
Financial health score
Out of 100, across five pillars of reported fundamentals.
What stands out
- Low debt (D/E 0x)
- Positive free cash flow and profitable
Sandu Pharmaceuticals Ltd vs the Consumer Staples median
| Metric | SANDUPHQ | Sector median | |
|---|---|---|---|
| PE ratioprice paid for each rupee of yearly profit | 19.23x | 15.18x | Weaker |
| Price to bookprice against the book value of assets | 0.78x | 1.61x | Better |
| EV / EBITDAbusiness value against operating profit | 7.93x | 11.91x | Better |
| Dividend yieldyearly dividend as a share of price | — | 0.8% | |
| Return on equityprofit on shareholders’ money | 4.1% | 9.3% | Weaker |
| ROCEprofit on all capital employed | 6.1% | 12.5% | Weaker |
| Net profit marginprofit kept from each rupee of sales | 2.5% | 3.6% | Weaker |
| Debt to equityborrowing against shareholders’ money | 0x | 0.31x | Better |
| Interest coveragehow many times profit covers interest | 25.09x | 4.15x | Better |
| Current ratioshort-term assets against short-term dues | 2.43x | 1.87x | Better |
| Revenue growth (1Y)change in sales over a year | 4.5% | 9.7% | Weaker |
| EPS growth (1Y)change in earnings per share over a year | 13.5% | 5.2% | Better |
| Promoter holdingshare owned by the founders or parent | 37.8% | 59.8% | Weaker |
| Promoter pledgepromoter shares pledged as loan security | 0% | 0% | In line |
| Betahow much it moves with the market | 1.22 | 0.88 | |
| 1-year returnshare price change over 52 weeks | -14.1% | -17% |
Tell DecideChart your amount, timeline and target return, and AI builds a full A4 report with risks, scenarios and worst cases. Your first report is free.
Other Consumer Staples companies
Hindustan Unilever LtdHINDUNILVR · score 73.8
ITC LtdITC · score 70.9
Nestle India LtdNESTLEIND · score 67.7
Varun Beverages LimitedVBL · score 75
Britannia Industries LtdBRITANNIA · score 67.1
Marico LimitedMARICO · score 71.7
Tata Consumer Products LtdTATACONSUM · score 59.6
United Spirits LimitedUNITDSPR · score 74.5
Godrej Consumer Products LtdGODREJCP · score 60.8
Dabur India LimitedDABUR · score 73.2
Radico Khaitan LimitedRADICO · score 74.7
Cupid LtdCUPID · score 77.3Frequently asked questions
What is the PE ratio of Sandu Pharmaceuticals Ltd?
Sandu Pharmaceuticals Ltd trades at a PE of 19.23x as of 5 November 2026, against a Consumer Staples median of 15.18x. PE is the price paid for each rupee of yearly profit.
Is Sandu Pharmaceuticals Ltd debt free?
Sandu Pharmaceuticals Ltd is practically debt free, with a debt-to-equity ratio of 0x.
What is the ROCE and ROE of Sandu Pharmaceuticals Ltd?
Sandu Pharmaceuticals Ltd has a return on capital employed of 6.1% and a return on equity of 4.1%. The Consumer Staples medians are 12.5% and 9.3%.
What is the DecideChart health score of Sandu Pharmaceuticals Ltd?
Sandu Pharmaceuticals Ltd scores 70.4 out of 100, graded Healthy. The score weighs profitability, debt, valuation, growth and governance from the company’s reported numbers. It is a research aid, not a recommendation.
Should I buy Sandu Pharmaceuticals Ltd shares?
DecideChart does not give buy or sell tips and is not linked to SEBI, BSE or NSE. Use these numbers for your own research, compare Sandu Pharmaceuticals Ltd with its Consumer Staples peers, and consult a SEBI-registered adviser before investing.
Fundamentals from a public market-data screener, as of 5 November 2026. Figures can lag company filings. DecideChart is AI-based, not linked to SEBI, BSE or NSE, and does not give investment advice.